FDA Approved: BONCRESA — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved BONCRESA (denosumab-mobz) from Amneal Pharmaceuticals LLC under an Original Application. It is indicated for conditions treated by denosumab, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases From Solid Tumors
• Postmenopausal Osteoporosis

Drugs mentioned

• BONCRESA (denosumab-mobz)

Snippet

ORIG AP for BONCRESA (DENOSUMAB-MOBZ)